Stuart, Graham and Higgins, Matthew (2007): The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry.
Download (282kB) | Preview
Since Comanor and Scherer (1969), researchers have been using patents as a proxy for new product development. In this paper, we reevaluate this relationship by using novel new data. We demonstrate that the relationship between patenting and new FDA-approved product introductions has diminished considerably since the 1950s, and in fact no longer holds. Moreover, we also find that the relationship between R&D expenditures and new product introductions is considerably smaller than previously reported. While measures of patenting remain important in predicting the arrival of product introductions, the most important predictor is the loss of exclusivity protection on a current product. Our evidence suggests that pharmaceutical firms are acting strategically with respect to new product introductions. Finally, we find no relationship between firm size and new product introductions.
|Item Type:||MPRA Paper|
|Institution:||Georgia Institute of Technology|
|Original Title:||The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry|
|Keywords:||Patenting; Pharmaceutical industry; New product management; Research productivity|
|Subjects:||O - Economic Development, Technological Change, and Growth > O3 - Technological Change; Research and Development; Intellectual Property Rights > O30 - General|
|Depositing User:||Matthew Higgins|
|Date Deposited:||23. Aug 2007|
|Last Modified:||13. Feb 2013 09:55|
Acs, Z., Audretsch, D., 1989. Entrepreneurial strategy and the presence of small firms. Small Business Economics 1, 193-213.
Ahuja, G., 2000. Collaboration networks, structural holes, and innovation: a longitudinal study. Administrative Science Quarterly 45, 425-455.
Aspden, H., 1983. Patent statistics as a measure of technological vitality. World Patent Information 5, 170-173.
Bloom, N., Van Reenen, J., 2002. Patents, real options and firm performance. The Economic Journal 112, C97-C116.
Bound, J., Cummins, C., Griliches, Z., Hall, B., Jaffe, A., 1984. Who does R&D and who patents? In Z. Griliches (ed.), R&D, Patents and Productivity. University of Chicago Press, Chicago, IL.
Bresman, H., Birkenshaw, J., Nobel, R., 1999. Knowledge transfer in international acquisitions. Journal of International Business Studies 30, 439-462.
Brouwer, E., Kleinknecht, A., 1999. Innovative output, and a firm’s propensity to patent. An exploration of CIS micro data. Research Policy 28, 615-624.
Cantwell, J., Hodson, C., 1991. Global R&D and UK competitiveness. In M. Casson (ed.), Global Research Strategy and International Competitiveness. Blackwell Scientific Publications, Oxford, pp. 133-182.
Cockburn, I., Griliches, Z., 1988. Industry effects and appropriability measures in the stock market’s valuation of R&D and patents. American Economic Review 78, 419-423.
Cohen, W., Nelson, R., Walsh, J., 2000. Patenting their intellectual assets: appropriability conditions and why U.S. manufacturing firms patent or not. NBER Working Paper 7522.
Comanor, W., Scherer, F.M., 1969. Patent statistics as a measure of technical change. Journal of Political Economy 77, 392–398.
DiMasi, J.A. 2001. New drug development in U.S. 1963-1999. Clinical Pharmacology and Therapeutics 69, 286-296.
Ernst, H., 2001. Patent applications and subsequent changes of performance: evidence from time-series cross-section analyses on the firm level. Research Policy 20, 143-157.
Fabrizio, K., 2004. Absorptive capacity and innovation: evidence from pharmaceutical and biotechnology firms. Unpublished working paper, Emory University.
Freeman, C., Soete, L., 1997. The Economics of Industrial Innovation. Pinter, London.
Graham, S.J.H, 2004. Continuation, complementarity, and capturing value: three studies exploring firms’ complementary uses of appropriability mechanisms in technological innovation. Ph.D. dissertation, University of California, Berkeley.
Graham, S.J.H., 2006. The determinants of patentees' use of 'continuation' applications in the United States patent and trademark office, 1980-99. In Andersen (ed.), Intellectual Property Rights: Innovation, Governance and the Institutional Environment. Edward Elgar Publishers.
Graham, S.J.H., Higgins, M.J., McKenzie, E., 2006. How well do markets value innovation in the pharmaceutical industry. Unpublished working paper, College of Management, Georgia Institute of Technology.
Graham, S.J.H., Mowery, D.C., 2003. Intellectual property protection in the software industry. In W. Cohen and S. Merrill (eds.), Patents in the Knowledge-based Economy: Proceedings of the Science, Technology and Economic Policy Board, National Academies Press 2003.
Griliches, Z., 1990. Patent statistics as economic indicators: a survey. Journal of Economic Literature 28, 1661-1707.
Griliches, Z., 1998. R&D and Productivity: The Econometric Evidence. The University of Chicago Press, Chicago.
Hagedoorn, J., Cloodt, M., 2003. Measuring innovative performance: is there an advantage in using multiple indicators? Research Policy 32, 1365-1379.
Hagedoorn, J., Schakenraad, J., 1994. The effect of strategic technology alliances on company performance. Strategic Management Journal 15, 291-309.
Hall, B., 2004. Exploring the Patent Explosion. Journal of Technology Transfer 30, 35-48.
Hall, B., Jaffe, A., Trajtenberg, M., 2001. The NBER Patent Citation Data File: Lessons, Insights, and Methodological Tools. NBER Working Paper 8498.
Hall, B., Jaffe, A., Trajtenberg, M., 2003. Market value and patent citations. Rand Journal of Economics 36, 16-38.
Harhoff , D., Hall B., 2003. Intellectual Property Strategy in the Global Cosmetics Industry, unpublished Discussion Paper, University of. Munich.
Harhoff, D., Scherer, F., Vopel, K., 2003. Citations, family size, opposition and the value of patent rights. Research Policy 32(8), 1343-1363.
Hausman, J., 1978. Specification tests in econometrics. Econometrica 46, 1251-1271.
Henderson, R., Cockburn, I., 1994. Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal 15, 63-84.
Higgins, M.J., Rodriguez, D., 2006. The outsourcing of R&D through acquisition in the pharmaceutical industry. Journal of Financial Economics 80, 351-383.
Jaffe, A., 1986. Technological opportunity and spillovers of R&D: evidence from firms’ patents, profits, and market value. American Economic Review 76, 984-1001.
Jensen, E., 1987. Research expenditures and the discovery of new drugs. The Journal of Industrial Economics 36, 83–95.
Kortum, S., Lerner, J., 1998. Stronger protection or technological revolution: what is behind the recent surge in patenting? Carnegie-Rochester Conference Series on Public Policy 48, 247-304.
Leamer, E.E., 1978. Specification Searches: Ad Hoc Inference from Non-Experimental Data. New York: Wiley.
_____, 1983. Let’s take the con out of econometrics. American Economic Review 73, 31-43.
_____, 1985. Sensitivity analyses would help. American Economic Review 75, 208-313.
_____, 1988. Measures in openness. In R. Baldwin (ed.), Trade Policy issues and Empirical Analysis, National Bureau of Economic Research Report Series, Chicago: University of Chicago Press, 147-200.
Levine, R. and Renelt, D. 1992. A Sensitivity Analysis of Cross-Country Growth Regressions. American Economic Review 82, 942–963.
Levin, R.C., Klevorick, A., Nelson, R., Winter, S., 1987. Appropriating the returns from industrial research and development. Brookings Papers on Economic Activity, 3.
Napolitano, G., Sirilli, G., 1990. The patent system and the exploitation of innovation of inventions: results of a statistical survey conducted in Italy. Technovation 10, 5-16.
Nohria, N., Gulati, R., 1996. Is slack good or bad for innovation? Academy Management Journal 39, 1245-1264.
Owen-Smith, J., Powell, W., 2004. Knowledge networks as channels and conduits: the effect of spillovers in the Boston technology community. Organization Science 15, 5-21.
Pakes, A., 1985. On patents, R&D, and the stock market rate of return. Journal of Political Economy 93, 390–409.
Patel, P., Pavitt, K., 1995. Divergence in technological development among countries and firms. In J. Hagedoorn (ed.), Technical Change and the World Economy: Convergence and Divergence in Technology Strategies. Edward Elgar, Aldershot, 147-181.
Pavitt, K., 1988. Uses and abuses of patent statistics. In A. van Raan (ed.), Handbook of Quantitative Studies of Science and Technology. Elsevier, Amsterdam, 509-536.
Rothaermel, F., Hess, A., 2007. Building dynamic capabilities: innovation driven by individual, firm, and network level effects. Organization Science 18, forthcoming.
Schmookler, J., 1962. Economic Sources of Inventive Activity. The Journal of Economic History 22, 1-20.
Shan, W., Walker, G., Kogut, B., 1994. Interfirm cooperation and startup innovation in the biotechnology industry. Strategic Management Journal 15, 387-394.
Stuart, T., 2000. Interorganizational alliances and the performance of firms: a study of growth and innovation rates in a high-technology industry. Strategic Management Journal 21, 791-811.
Thursby, J., Thursby, M., 2006. Here or There? A Survey on the Factors in Multinational R&D Location -- Report to the Government-University-Industry Research Roundtable. National Academies Press.
Trajtenberg, M., 1990. A penny for your quotes: patent citations and the value of innovations. The Rand Journal of Economics 21, 172-187.
Wall Street Journal, 2004. Drug industry’s big push into technology falls short. February 24.